Actively Recruiting

Age: 18Years +
All Genders
NCT05336760

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Led by University Rehabilitation Institute, Republic of Slovenia · Updated on 2024-10-15

60

Participants Needed

1

Research Sites

169 weeks

Total Duration

On this page

Sponsors

U

University Rehabilitation Institute, Republic of Slovenia

Lead Sponsor

U

University Medical Centre Ljubljana

Collaborating Sponsor

AI-Summary

What this Trial Is About

In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.

CONDITIONS

Official Title

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Diagnosis of Amyotrophic Lateral Sclerosis (ALS)
  • Follow-up at University Medical Centre Ljubljana, Division of Neurophysiology, every 3 months
  • Ability to visit the study site for in-person procedures every 3 months
  • Relatives must be at least 18 years of age
Not Eligible

You will not qualify if you...

  • Presence of any illness or disorder affecting swallowing function independently of ALS
  • Clinically significant cognitive deterioration or dementia at enrollment, as determined by the ALS study neurologist
  • Relatives showing signs of probable cognitive deterioration or dementia at enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Medical Centre Ljubljana

Ljubljana, Slovenia, 1000

Actively Recruiting

Loading map...

Research Team

M

Metka Moharić, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here